TADA3L isoforms are highly expressed in CD34+ stem cells [57], but we find that TADA3L is relatively methylated in IUGR at a CpG island-containing bidirectional promoter, potentially downregulating its expression and altering CD34+ stem cell population dynamics. The gene discussed is CD34; the disease is fetal growth restriction.